Effect of Epigallocatechin-3-Gallate Solution as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Necrotic Tooth
1 other identifier
interventional
40
1 country
1
Brief Summary
clinically compare the intensity of post-operative pain and the amount of bacterial load reduction after using 20% Epigallocatechin-3-gallate solution during chemomechanical preparation, versus 2.5% NaOCl, in asymptomatic necrotic mandibular premolars treated in a single visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedJanuary 10, 2025
January 1, 2025
10 months
July 27, 2023
January 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain
Categorical None 0 Mild 1-3 Moderate 4-6 Severe 7-10
Postoperative pain measured at 6, 12, 24, 48 hours after single visit treatment.
Secondary Outcomes (1)
Amount of intracanal bacterial load reduction
T0: preintervention, preinstrumentation after access cavity. T1: postinstrumentation up to 10 min
Study Arms (2)
Epigallocatechin-3-Gallate
EXPERIMENTAL20% Epigallocatechin-3-Gallate solution
sodium hypochlorite
ACTIVE COMPARATOR2.5% sodium hypochlorite
Interventions
to be used as a root canal irrigant
Eligibility Criteria
You may qualify if:
- Systematically healthy patient (ASA I, II).
- Age between 18 and 45 years
- Male or female.
- Asymptomatic mandibular premolar teeth diagnosed with pulp necrosis.
You may not qualify if:
- Medically compromised patients having significant systemic disorders. (ASA III or IV).
- Teeth with:
- Immature roots
- Association with swelling or sinus tract.
- Acute peri-apical abscess or acute exacerbation of a chronic abscess.
- Mobility Grade II or III
- Previously accessed or endodontically treated
- Deep periodontal pockets more than 4 mm
- Vertical root fractures, coronal perforation, calcification, and external or internal root resorptions.
- Patients who could not interpret the NRS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Dentistry
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
rayan adlan
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 27, 2023
First Posted
August 14, 2023
Study Start
October 1, 2023
Primary Completion
July 30, 2024
Study Completion
July 30, 2024
Last Updated
January 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF